socalTECH

MAY 20, 2016

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration. READ MORE>>.

Avalon 113

Avalon Company Companies San Diego 113

socalTECH

OCTOBER 18, 2012

San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. Selectable Media, which is based in New York, lets users opt into branded video advertising in exchange for free access to content on web and mobile apps. READ MORE>>.

Avalon 147

Avalon Media San Diego Advertising 147

socalTECH

OCTOBER 13, 2011

La Jolla-based venture capital investor Avalon Ventures is the lead in a round for cloud data storage firm TwinStrata , TwinStrata said today. TwinStrata, which is based in Masachusetts, said that Avalon lead its Series B funding round, which was worth $8M. Avalon's investment in TwinStrata was headed by Rich Levandov.

Avalon 140

Avalon Venture Capital Capital Invest 140

socalTECH

JUNE 15, 2015

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100

Avalon San Diego Startup Funding 100

socalTECH

DECEMBER 2, 2010

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.

Avalon 154

Avalon Invest Cloud Computing San Diego 154

socalTECH

OCTOBER 20, 2014

San Diego-based therapeutic antibody developer AnaptysBio announced this morning that it has named Marco Londei as its Chief Development Officer. AnaptysBio is backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures, Novo A/S, Numenor Ventures, WS Investments, and others. READ MORE>>.

Develop 147

Develop Development Avalon San Diego 147

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

JUNE 11, 2021

Janux Therapeutics is developing T cell engager immunotherapies. The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures. The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113

Pricing Avalon Capital Marketing 113

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

MARCH 31, 2020

San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round.

Funding 140

Funding Avalon San Diego Platform 140

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JULY 28, 2020

San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. AristaMD develops telehealth software used for virtual consultations, allowing primary care physicians to consult with medical specialists virtually.

Funding 100

Funding Avalon San Diego Software Development 100

socalTECH

APRIL 17, 2017

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. to its board of directors. Gorman replaces director Robert Baltera, Jr.,

Avalon 113

Avalon Monrovia Develop Development 113

socalTECH

NOVEMBER 13, 2019

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124

Avalon San Diego Incubator Technology 124

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing.

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

JULY 14, 2017

San Diego-based StackIQ , a developer of "bare metal" provisioning software, has been acquired by Teradata , Teradata said on Thursday. StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. Financial terms of the acquisition were not announced.

Avalon 113

Avalon Anthem San Diego Acquisition 113

socalTECH

SEPTEMBER 27, 2016

The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. The startup, based in the COI Pharmaceuticals cluster of companies in San Diego, is based on research developed by Bin Liu, Ph.D., READ MORE>>.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. The company is led by Tim McIntire.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

socalTECH

JANUARY 9, 2014

The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. Avelas Biosciences is developing a flourecent peptide which helps surgeons highlight cancer cells during surgery, specifically for breast cancer. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

DECEMBER 6, 2012

The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients. The firm's technology is based on technology developed by Nobel Prize winner Roger Tsien, Ph.D. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

MARCH 5, 2013

San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

AUGUST 23, 2017

Pasadena- and Boston-based Axial Biotherapeutics , which is developing treatments for neurological diseases, said on Tuesday that it has named Srinivas G. as its Chief Medical Officer, Ryan Barrett as Vice President, Corporate Development and Intellectual Property, and Bridget M. Cole, Ph.D. as Vice President of Medicinal Chemistry.

Avalon 113

Avalon Pasadena Develop Development 113

socalTECH

NOVEMBER 28, 2016

San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. Doyle as its Chief Business Officer. The company announced a funding round in July.

Avalon 100

Avalon San Diego Capital Funding 100

socalTECH

AUGUST 18, 2016

San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. and laos included Ervington Investments Limited and Alexandria Venture Investments plus Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures.

Avalon 100

Avalon San Diego Invest Funding 100

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. in its IPO, and closed up slightly in its first day of trading on Thursday.

Avalon 100

Avalon San Diego Pricing Invest 100

Xconomy

JANUARY 29, 2020

Agenda topics include Successful Research & Development Models, What It Takes for Commercialization, and Building a Biotech Ecosystem in San Diego. Speakers include Jay Lichter, CEO of COI Pharma and Managing Director at Avalon Ventures; Ciara Kennedy, CEO of Amplyx; and Kim Kamdar, Partner at Domain Associates. $99

San Diego 79

San Diego Avalon Research Ideas 79

socalTECH

JULY 14, 2014

San Diego-based Otonomy , the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Market. Otonomy said it intends to list under the symbol OTIC. Otonomy''s IPO is being underwritten by J.P.

Avalon 147

Avalon San Diego Acquisition Marketing 147

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.

Funding 138

Funding Avalon San Diego Capital 138

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

SEPTEMBER 5, 2013

San Diego-based server side caching software developer Proximal Data has inked a deal with LSI Corporation , where LSI will integrate its server-side caching technology with a PCIe flash application acceleration product. Proximal Data is venture backed by Divergent Ventures and Avalon Ventures. READ MORE>>.

Avalon 138

Avalon San Diego Software Development Software 138

socalTECH

AUGUST 13, 2014

The company is developing treatments for disorders of the inner ear. Otonomy was backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, and Rivervest Venture Partners. The company raised $100M in the IPO. The company priced at the high end of its initial estimated IPO range, which was $14.00

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

DECEMBER 2, 2013

The developer of portable oxygen concentrators -- used as an alternative to bulky, oxygen canisters for those with chronic respiratory conditions like COPD -- said it plans to raised up to $86.25M in its public debut. Inogen is venture backed by Novo A/S, Versant Ventures, Arboretum Ventures, Avalon Ventures, AMV Partners, and others.

Avalon 153

Avalon Acquisition Marketing Develop 153

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receive funding of costs incurred in related development programs, as part of an antibody program.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

JULY 22, 2016

San Diego-based AristaMD , which is developing software tools to help coordinate referrals by physicians to specialists, has raised $11M in a Series A funding round. The funding was led by Avalon Ventures, and also included Correlation Ventures.

Avalon 100

Avalon San Diego Tool Research 100

socalTECH

JUNE 23, 2015

La Jolla-based Ankasa Regenerative Therapeutics , a company developing stem-cell based products aimed at organ and tissue regrowth, repair, and healing, has raised $8.5M The funding was led by Avalon Ventures, and also included Hereaus Medical and Correlation Ventures. in a Series A funding, the company said this morning.

Avalon 100

Avalon Organization Funding Startup 100